phosphorylcholine has been researched along with Heart Failure in 2 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Heart failure is a prevalent disorder whose prognosis remains poor despite advances in treatment." | 1.91 | Metabolomic Profiling of Cardiac Fibrosis and Steatosis in Women With or at Risk for HIV. ( Ambale-Venkatesh, B; Anastos, K; Kaplan, RC; Kato, Y; Kizer, JR; Lazar, JM; Lima, JAC; Naveed, M; Qi, Q; Shitole, SG; Tien, PC; Wang, T; Wang, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shitole, SG | 1 |
| Naveed, M | 1 |
| Wang, Z | 1 |
| Wang, T | 1 |
| Kato, Y | 1 |
| Ambale-Venkatesh, B | 1 |
| Kaplan, RC | 1 |
| Tien, PC | 1 |
| Anastos, K | 1 |
| Lazar, JM | 1 |
| Lima, JAC | 1 |
| Qi, Q | 1 |
| Kizer, JR | 1 |
| Li, WJ | 1 |
| Liao, HH | 1 |
| Feng, H | 1 |
| Zhou, ZY | 1 |
| Mou, SQ | 1 |
| Zhang, N | 1 |
| Wu, HM | 1 |
| Xia, H | 1 |
| Tang, QZ | 1 |
2 other studies available for phosphorylcholine and Heart Failure
| Article | Year |
|---|---|
Metabolomic Profiling of Cardiac Fibrosis and Steatosis in Women With or at Risk for HIV.
Topics: Cardiomyopathies; Fatty Liver; Female; Fibrosis; Heart Failure; HIV Infections; Humans; Phosphorylch | 2023 |
Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Glycogen Synthase Kinase 3 beta; Heart F | 2020 |